The pancreatic hormone amylin is released from beta cells following nutrient ingestion and
contributes to the control of body weight and glucose homeostasis. Amylin reduces food …

AdipoRon, an adiponectin receptor agonist, elicits similar antidiabetic, anti-atherogenic, and
anti-inflammatory effects on mouse models as adiponectin does. Since AdipoRon can cross …

Accumulating evidence indicates that diet and body weight are important factors associated
with Alzheimer's disease (AD), with a significant increase in AD risk linked to mid-life obesity …

The adipocyte-derived hormone leptin is an important regulator of body weight and
metabolism through activation of brain leptin receptors expressed in regions such as the …

Amylin is a pancreatic β‐cell hormone that acts as a satiating signal to inhibit food intake by
binding to amylin receptors (AMY s) and activating a specific neuronal population in the area …

Diet‐induced obesity is associated with hypothalamic inflammation and this phenomenon
has been proposed to explain leptin resistance. In the present study, we used a short‐term …

There is accumulating evidence from epidemiological studies that changes in body weight
are associated with Alzheimer's disease (AD) from mid-life obesity increasing the risk of …

Administration of exercise mimetic drugs could be a novel therapeutic approach to combat
comorbid neurodegeneration and metabolic syndromes. Adiponectin is an adipocyte …

Leptin is a centrally acting hormone controlling metabolic pathways. Recently, it was shown
that leptin can reduce amyloid β levels both in vitro and in vivo. Herein, phosphorylation of …

Amylin phosphorylates ERK (p-ERK) in the area postrema to reduce eating and synergizes
with leptin to phosphorylate STAT3 in the arcuate (ARC) and ventromedial (VMN) …